http://www.exelixis.com
Exelixis, Inc. Company Intro
We drive to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future. Cancer is our cause.
Industry
Healthcare
Exelixis, Inc. Headquaters
1851 Harbor Bay Parkway
Alameda,94502
United States
Exelixis, Inc. Share price
14 Sep 2022 09:11 GMT
$17.78
-0.19 (-1.06 %)
Exelixis, Inc. Market cap
$5.423 B
WMC RANKING
2022
Exelixis, Inc. # 12
BiotechnologyLatest Exelixis, Inc. News
23 Sep 2022
DnB Asset Management AS Grows Stock Position in Exelixis ...
Other hedge funds also recently made changes to their positions in the company. Crossmark Global Holdings Inc. grew its position in shares of Exelixis by 2.6%...
23 Sep 2022
Timing, Fundamentals, and Diversification of Exelixis Inc. (EXEL)
The closing price of Exelixis Inc. (NASDAQ: EXEL) was 16.57 for the day, up 0.42% from the previous closing price of $16.50. In other words, the price has...
23 Sep 2022
Which Institutions Own Shares In Sorrento Therapeutics Inc ...
The company's main competitors (and peers) include Exelixis Inc. (EXEL) that is trading -17.97% down over the past 12 months and Karyopharm Therapeutics...
WMC Market Score
WMC Market to Revenue Score
Exelixis, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Exelixis, Inc. | USD | $1,030,853 | $938,028 | $64,770 | $54,230B | 12 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Exelixis, Inc. Social Followers vs Top 4 Industry Competitors
Exelixis, Inc. Post vs Top 4 Industry Competitors
Exelixis, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Exelixis, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Exelixis, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Exelixis, Inc. | 11.21 | 12.71 | 0.05 | 0 | 0 | 0 | 5.75 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 33 | 0 | 0 | 14.66 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
